GFAP and amyotrophic lateral sclerosis: The quantitative analysis revealed that in ALS serum treated mice, in the ventral horns of the lumbar spinal cord, the GFAP-positive relative area fraction raised to 20.61% ± 1.51% compared with the 13.66% ± 0.22% control value (p = 0.0012; Student t-test).